Abstract
Background: Hormone replacement therapy (HRT) is associated with reduced cardiovascular risk, but the underlying mechanism(s) are not fully understood. This study investigated the effects of a 6‐month course of HRT on cardiac autonomic function parameters assessed by heart rate variability (HRV) in postmenopausal women.
Methods: Forty‐six healthy postmenopausal women (age 48 ± 5, range 40–60) with normal baseline electrocardiogram and negative exercise testing were enrolled. HRT, which was either 0.625 mg/day conjugated equine estrogen (CEE) plus 2.5 mg/day medroxyprogesterone acetate or 0.625 mg/day CEE alone were administered depending on hysterectomy status. Power spectral analysis of HRV was performed to calculate the low frequency component in absolute (LF) and normalized units (LF nu), high frequency component in absolute (HF), and normalized units (HF nu), and the LF/HF ratio. The standard deviation of RR intervals (SDNN) was calculated from the time series of RR intervals.
Results: A 6‐month course of HRT did not significantly alter resting heart rate (P > 0.05). The LF/HF ratio and LF nu significantly decreased after HRT (P = 0.022 and P = 0.032), whereas a significant increase was noted in the HF component of HRV (P = 0.043), indicating an improvement in cardiac autonomic function. The SDNN value, which was 28.8 ± 11.8 ms before HRT significantly increased to 35.4 ± 16.7 ms after 6 months (P = 0.011).
Conclusion: Our results indicate that a 6‐month course of HRT may significantly improve cardiac autonomic function parameters, a finding that could at least partly explain the potential cardiopro‐tective effect(s) of HRT. A.N.E. 2001;6(4):280–284
Keywords: hormone replacement therapy, heart rate variability, menopause
REFERENCES
- 1. Grodstein F, Stampfer MJ, Manson JE, et al. Postmeno‐pausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453–461. [DOI] [PubMed] [Google Scholar]
- 2. Stevenson JC, Crook D, Godsland IF, et al. Hormone replacement therapy and the cardiovascular system. Nonlipid effects. Drugs 1994;47(Suppl. 2):35–41. [DOI] [PubMed] [Google Scholar]
- 3. Campbell RWF. Can Analysis of Heart Rate Variability Predict Arrhythmias and Antiarrhythmic Effects? Chapter In Oto A. (ed): Practice and Progress in Cardiac Pacing and Electrophysiology. Amsterdam , Netherlands , Kluwer Academic Publishers, 1996, pp. 63–69. [Google Scholar]
- 4. Fallen EL, Kamath MV, Ghista DN. Power spectrum of heart rate variability: A noninvasive test of integrated neurocardiac function. Clin Invest Med 1988;11:331–340. [PubMed] [Google Scholar]
- 5. La Rovere MT, Bigger JT Jr, Marcus FI, et al. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998;351: 478–484. [DOI] [PubMed] [Google Scholar]
- 6. Bigger JT Jr, Fleiss JL, Steinman RC, et al. Frequency domain measures of heart rate variability and mortality after myocardial infarction. Circulation 1992;85:164–171. [DOI] [PubMed] [Google Scholar]
- 7. Rosano GM, Patrizi R, Leonardo F, et al. Effect of estrogen replacement therapy on heart rate variability and heart rate in healthy postmenopausal women. Am J Cardiol 1996;80: 815–817. [DOI] [PubMed] [Google Scholar]
- 8. Virtanen I, Polo‐Kantola P, Erkkola R, et al. Climacteric vasomotor symptoms do not imply autonomic dysfunction. Br J Obstet Gynecol 1999;106:155–164. [DOI] [PubMed] [Google Scholar]
- 9. Christ M, Seyffart K, Wehling M. Attenuation of heart‐rate variability in postmenopausal women on progestin‐containing hormone replacement therapy. Lancet 1999;353:1939–1940. [DOI] [PubMed] [Google Scholar]
- 10. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 1996;93: 1043–1065. [PubMed] [Google Scholar]
- 11. Tokgozoglu SL, Batur MK, Topcuoglu MA, et al. Effects of stroke localization on cardiac autonomic balance and sud den death. Stroke 1999;30:1307–1311. [DOI] [PubMed] [Google Scholar]
- 12. McKinlay SM, Jefferys M. The menopausal syndrome. Br J Prev Soc Med 1974;28:108–115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Ramaekers D, Ector H, Aubert AE, et al. Heart rate variability and heart rate in healthy volunteers: Is the female autonomic nervous system cardioprotective Eur Heart J 1998;19:1334–1341. [DOI] [PubMed] [Google Scholar]
- 14. Du XJ, Riemersma RA, Dart AM. Cardiovascular protection by estrogen is partly mediated through modulation of autonomic nervous function. Cardiovasc Res 1995;30:161–165. [PubMed] [Google Scholar]
- 15. McCabe PM, Porges SW, Carter CS. Heart period variability during estrogen exposure and withdrawal in female rats. Physiol Behav 1981;26:535–538. [DOI] [PubMed] [Google Scholar]
- 16. Stumpf WE. Steroid hormones and the cardiovascular system: Direct actions of estradiol, progesterone, testosterone, gluco‐ and mineralocorticoids and soltriol (vitamin D) on central nervous regulatory and peripheral tissues. Experientia 1990;46:13–25. [DOI] [PubMed] [Google Scholar]